EHRA Premium Access

Indexes of anticoagulation control and major adverse outcomes in patients with atrial fibrillation: an analysis from the AFFIRM Trial

Congress Presentation

About the speaker

Associate Professor Marco Proietti

University of Milan, Milan (Italy)
11 presentations
0 follower

8 more presentations in this session

Quality of Anticoagulation Control and Major Adverse Outcomes in European Patients with Atrial Fibrillation: Analysis from EORP-AF General Long-Term Registry

Speaker: Associate Professor M. Proietti (Milan, IT)


The influence of NOAC on sudden neurological death

Speaker: Doctor B. Slavchev (Sofia, BG)


Ischemic stroke in patient with sinus node disease in comparison to atrial fibrillation, bradycardia-tachycardia syndrome and other cardiac conditions: a nationwide cohort-study

Speaker: Doctor A. Bodin (Tours, FR)


Morpho-functional analysis of the left atrium appendage for stroke risk assessment in atrial fibrillation

Speaker: Doctor C. Tomasi (Ravenna, IT)


Characteristics associated with death in patients with atrial fibrillation initiated on rivaroxaban and followed up for 1 year on treatment - an analysis in the pooled XANTUS data

Speaker: Professor J. Camm (London, GB)


Access the full session

Poster session 3 - Atrial Fibrillation - Stroke Prevention

Speakers: Associate Professor M. Proietti, Associate Professor M. Proietti, Doctor B. Slavchev, Doctor A. Bodin, Doctor C. Tomasi...

About the event


EHRA 2019

17 March - 19 March 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb